Phase 3 Trial for Pediatric Growth Hormone Deficiency in China Completed Enrollment On Time Despite COVID-19 Setback

VISEN Pharmaceuticals has recently announced that enrollment has been completed for their Phase 3 clinical trial examining the safety and efficacy of TransCon hGH compared to daily rhGH in patients…

Continue Reading Phase 3 Trial for Pediatric Growth Hormone Deficiency in China Completed Enrollment On Time Despite COVID-19 Setback
Case Study: Guillain-Barre Syndrome in a Patient with Severe COVID-19
source: pixabay.com

Case Study: Guillain-Barre Syndrome in a Patient with Severe COVID-19

In a case study published on dovepress.com, a 17 year old girl diagnosed with COVID-19 developed Guillain-Barre syndrome, a neurological disease causing muscle weakness, as her symptoms progressed. While COVID-19…

Continue Reading Case Study: Guillain-Barre Syndrome in a Patient with Severe COVID-19
Study Finds Thrombosis May be the First Sign of Granulomatosis with Polyangiitis
source: pixabay.com

Study Finds Thrombosis May be the First Sign of Granulomatosis with Polyangiitis

A recent study has found that thrombosis may be the first manifestation of granulomatosis with polyangiitis disease in children following the very first report of its presentation in a 13…

Continue Reading Study Finds Thrombosis May be the First Sign of Granulomatosis with Polyangiitis
Study Finds Consistent Exercise Can Have Positive Physical and Mental Health Benefits for Pulmonary Hypertension Patients
source: pixabay.com

Study Finds Consistent Exercise Can Have Positive Physical and Mental Health Benefits for Pulmonary Hypertension Patients

A recent study has found that aerobic and strength training exercise programs can have a long term effect on physical functioning for patients with pulmonary hypertension (PH). PH is a…

Continue Reading Study Finds Consistent Exercise Can Have Positive Physical and Mental Health Benefits for Pulmonary Hypertension Patients
Investigative Therapy for Duchenne Muscular Dystrophy is in a Phase 3 Clinical Trial
Source: Pixabay

Investigative Therapy for Duchenne Muscular Dystrophy is in a Phase 3 Clinical Trial

FibroGen has just announced that their investigative therapy pamrevlumab, for Duchenne muscular dystrophy (DMD), has received Rare Pediatric Disease designation from the FDA. The treatment already was given Fast Track…

Continue Reading Investigative Therapy for Duchenne Muscular Dystrophy is in a Phase 3 Clinical Trial
Results from Phase 1 HATTR Amyloidosis Trial Presented at Recent Meeting
source: pixabay.com

Results from Phase 1 HATTR Amyloidosis Trial Presented at Recent Meeting

According to a story from globenewswire.com, the clinical company Prothena Corporation plc recently presented encouraging results from its phase 1 clinical trial. This trial was evaluating its investigational product candidate…

Continue Reading Results from Phase 1 HATTR Amyloidosis Trial Presented at Recent Meeting
Patients with Unresectable Colorectal Liver Metastases and KRAS Mutations Show Reduced Response Rates
source: pixabay.com

Patients with Unresectable Colorectal Liver Metastases and KRAS Mutations Show Reduced Response Rates

  Researchers have been able to identify similarities in outcomes between colorectal liver metastases that cannot be completely removed by surgery (unresectable) and patients with the KRAS mutation. Surgical resection…

Continue Reading Patients with Unresectable Colorectal Liver Metastases and KRAS Mutations Show Reduced Response Rates